Clinical Trials Logo

Clinical Trial Summary

The addition of probiotics to the routine therapy of Acute Pharyngotonsillitis in adult patients may shorten the duration, and reduce the severity of the disease.


Clinical Trial Description

Hypothesis The addition of probiotics to the routine therapy of AP in adult patients may shorten the duration, and reduce the severity of the disease.

Study design A prospective, randomized, placebo-controlled, double-blinded study comparing treatment with probiotics to placebo in patients with AP.

The study will be conducted in accordance with the ethical standards of the Helsinki Declaration and will be approved by the Human Experimentation Ethics Committee of the Ziv Medical Center. Signed informed consent will be required from all patients before inclusion. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01679366
Study type Interventional
Source Ziv Hospital
Contact
Status Completed
Phase Phase 3
Start date October 2012
Completion date October 2013

See also
  Status Clinical Trial Phase
Completed NCT02894372 - Faringomoss Effectiveness in Inhibiting Acute Throat Pain and Discomfort N/A
Terminated NCT01777854 - Anti-reflux Control to Decrease Post Tonsillectomy Pain Phase 4
Enrolling by invitation NCT06168981 - The Effect of Preoperative Chewing Gum on Anxiety and Sore Throat in Patients With Laryngeal Mask Airway N/A